Authors
Loading...
Randomized trial demonstrates that inhibiting PLD1 and PLD2 enhances immune activation in tumors, indicating therapeutic potential.
Lee et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: